A Prospective Pilot Study to Evaluate a New Marker of Ischemia in Chest Pain Triage
A Prospective Pilot Study to Evaluate a New Marker of Ischemia in Chest Pain Triage
A Single-center prospective pilot study enrolling chest pain patients. CD 26 measurement will
 be performed and compared to troponin µs for early triage of these patients. This novel
 biomarker of myocardial ischemia (CD26) will be measured at the time of first medical contact
 (T0) and after 30 min simultaneously o troponin Ic.

 All patients aged over 18 years with chest pain which may be related to acute coronary
 syndrome requiring pre hospital medical contact through the Emergency Medical Service.
First objectives: demonstrating the early positivity of CD26 compared to ultra-sensitive
 troponin.
Inclusion Criteria:

 -  Subject with compatible symptoms with an acute coronary syndrome, for at least 15
 minutes and not older than 3 hours (eg discomfort, tightness or chest pain, pain
 radiating to the left arm or two arms, pain in the jaw, pain in the back / neck /
 stomach, breathlessness , cold sweats, nausea / vomiting , dizziness )

 -  Man or woman,

 -  Patient Did not receive heparin or low molecular weight heparin (LMWH ) before the
 initial blood sample ,

 -  Patient Agreeing to participate in the study and who signed an informed consent

 Exclusion Criteria:

 -  Minor or major patient trust

 -  Patient Not having signed informed consent (refusal , physical or mental disability
 ... )

 -  Patient Who received anticoagulation before carrying blood samples

 -  Patient With a progressive septic processes , neoplasia undergoing treatment, dialyzed
 kidney failure, a history of surgery or coronary angioplasty less than six months.

 -  Transplanted heart, renal or hepatic

 -  heart attack

 -  Subject Whose symptoms clearly eliminates acute coronary syndrome ( penetrating
 trauma, traumatic injury by crushing ... )

 -  Patient Died between the time of inclusion and arrival in the cardiology intensive
 care ( SIC )

 -  Patient Withdrawing consent under study